Erratum: FGFR1 expression and gene copy numbers in human lung cancer (Virchows Archiv (2012) 461 (49-57) DOI: 10.1007/s00428-012-1250-y);FGFR1 expression and gene copy numbers in human lung cancer

Virchows Archiv

Volumn 461, Issue 1, 2012, Pages 49-57

  Kohler, Lukas H ^a   Mireskandari, Masoud ^a   Knösel, Thomas ^a,d   Altendorf Hofmann, Annelore ^a   Kunze, Almut ^b   Schmidt, Andreas ^b   Presselt, Norbert ^c   Chen, Yuan ^a   Petersen, Iver ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Central Clinic Bad Berka   (Germany)

^c Central Clinic Bad Berka   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

FGFR1; FGFR1 amplification; FGFR1 expression; Lung cancer

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHROMOSOME 8; CHROMOSOME 8P; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

EID: 84864277372     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1294-z     Document Type: Erratum

References (37)

1. A Jemal R Siegel E Ward T Murray J Xu C Smigal MJ Thun 2006 Cancer statistics, 2006 CancerJClin 56 106 130
2. GEKID/RKI (2012) Krebs in Deutschland 2007/2008. 8. Ausgabe. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg). Berlin, 2012
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2008) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase no. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010
4. N Turner R Grose 2010 Fibroblast growth factor signalling: from development to cancer Nat Rev Cancer 10 2 116 129 20094046 10.1038/nrc2780 1:CAS:528:DC%2BC3cXps1Gktg%3D%3D
5. D Prié FG Reciprocal 2010 Control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system Clin J Am Soc Nephrol 5 1717 1722 20798257 10.2215/CJN.02680310
6. H Greulich MP Pollock 2011 Targeting mutant fibroblast growth factor receptors in cancer Trends Mol Med 17 5 283 292 21367659 10.1016/j.molmed.2011. 01.012 1:CAS:528:DC%2BC3MXmtFansLs%3D
7. AJ Bass H Watanabe CH Mermel S Yu S Perner RG Verhaak SY Kim L Wardwell P Tamayo I Gat-Viks AH Ramos MS Woo BA Weir G Getz R Beroukhim M O'Kelly A Dutt O Rozenblatt-Rosen P Dziunycz J Komisarof LR Chirieac CJ Lafargue V Scheble T Wilbertz C Ma S Rao H Nakagawa DB Stairs L Lin TJ Giordano P Wagner JD Minna AF Gazdar CQ Zhu MS Brose I Cecconello U Ribeiro Jr SK Marie O Dahl RA Shivdasani MS Tsao MA Rubin KK Wong A Regev WC Hahn DG Beer AK Rustgi M Meyerson 2009 SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas Nat Genet 41 1238 1242 19801978 10.1038/ng.465 1:CAS:528: DC%2BD1MXht1Wgsb3M
8. J Weiss ML Sos D Seidel M Peifer T Zander JM Heuckmann RT Ullrich R Menon S Maier A Soltermann H Moch P Wagener F Fischer S Heynck M Koker J Schöttle F Leenders F Gabler I Dabow S Querings LC Heukamp H Balke-Want S Ansén D Rauh I Baessmann J Altmüller Z Wainer M Conron G Wright P Russell B Solomon E Brambilla C Brambilla P Lorimier S Sollberg OT Brustugun W Engel-Riedel C Ludwig I Petersen J Sänger J Clement H Groen W Timens H Sietsma E Thunnissen E Smit D Heideman F Cappuzzo C Ligorio S Damiani M Hallek R Beroukhim W Pao B Klebl M Baumann R Buettner K Ernestus E Stoelben J Wolf P Nürnberg S Perner RK Thomas 2011 Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer Sci Transl Med 2 62 93
9. PS Hammerman ML Sos AH Ramos C Xu A Dutt W Zhou LE Brace BA Woods W Lin J Zhang X Deng SM Lim S Heynck M Peifer JR Simard MS Lawrence RC Onofrio HB Salvesen D Seidel T Zander JM Heuckmann A Soltermann H Moch M Koker F Leenders F Gabler S Querings S Ansén E Brambilla C Brambilla P Lorimier OT Brustugun A Helland I Petersen JH Clement H Groen W Timens H Sietsma E Stoelben J Wolf DG Beer MS Tsao M Hanna C Hatton MJ Eck PA Janne BE Johnson W Winckler H Greulich AJ Bass J Cho D Rauh NS Gray KK Wong EB Haura RK Thomas M Meyerson 2011 Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer Cancer Discov 1 1 78 89 22328973 10.1158/2159-8274.CD- 11-0005 1:CAS:528:DC%2BC3MXpsVylsbg%3D
10. R Thomas J Wolf 2012 Personalized therapy of lung cancer Onkologie 35 Suppl 1 14 19 22286583 10.1159/000334827 1:CAS:528:DC%2BC38Xhs1Kmurs%3D
11. Z Hamidov A Altendorf-Hofmann Y Chen U Settmacher I Petersen T Knösel 2011 Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma J Clin Pathol 64 11 990 994 21725043 10.1136/jclinpath-2011- 200099
12. L Dailey D Ambrosetti A Mansukhani C Basilico 2005 Mechanisms underlyingd differential responses to FGF signaling Cytokine Growth Factor Rev 16 233 247 15863038 10.1016/j.cytogfr.2005.01.007 1:CAS:528:DC%2BD2MXjvVOnsLs%3D
13. D Ribatti A Vacca M Rusnati M Presta 2007 The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies Cytokine Growth Factor Rev 18 327 334 17537668 10.1016/j.cytogfr.2007.04.011 1:CAS:528:DC%2BD2sXmsFCms70%3D
14. F Courjal M Cuny J Simony-Lafontaine G Louason P Speiser R Zeillinger C Rodriguez C Theillet 1997 Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups Cancer Res 57 19 4360 4367 9331099 1:CAS:528:DyaK2sXmsFCgsrs%3D
15. R Simon J Richter U Wagner A Fijan J Bruderer U Schmid D Ackermann R Maurer G Alund H Knönagel M Rist K Wilber M Anabitarte F Hering T Hardmeier A Schönenberger R Flury P Jäger JL Fehr P Schraml H Moch MJ Mihatsch T Gasser G Sauter 2001 High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer Cancer Res 61 11 4514 4519 11389083 1:CAS:528:DC%2BD3MXktlWjs7g%3D
16. KL Gorringe S Jacobs ER Thompson A Sridhar W Qiu DY Choong IG Campbell 2007 High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications Clin Cancer Res 13 16 4731 4739 17699850 10.1158/1078-0432.CCR-07-0502 1:CAS:528: DC%2BD2sXptVGmtro%3D
17. E Missiaglia J Selfe M Hamdi D Williamson G Schaaf C Fang J Koster B Summersgill B Messahel R Versteeg K Pritchard-Jones M Kool J Shipley 2009 Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development Genes Chromosomes Cancer 48 6 455 467 19235922 10.1002/gcc.20655 1:CAS:528:DC%2BD1MXltlagsrs%3D
18. D Cappellen C De Oliveira D Ricol S de Medina J Bourdin X Sastre-Garau D Chopin JP Thiery F Radvanyi 1999 Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas Nat Genet 23 18 20 10471491 1:CAS:528: DyaK1MXlvFWhs7s%3D
19. A Dutt HB Salvesen TH Chen AH Ramos RC Onofrio C Hatton R Nicoletti W Winckler R Grewal M Hanna N Wyhs L Ziaugra DJ Richter J Trovik IB Engelsen IM Stefansson T Fennell K Cibulskis MC Zody LA Akslen S Gabriel KK Wong WR Sellers M Meyerson H Greulich 2008 Drug sensitive FGFR2 mutations in endometrial carcinoma Proc Natl Acad Sci 105 8713 8717 18552176 10.1073/pnas.0803379105 1:CAS:528:DC%2BD1cXot1agtLw%3D
20. K Kunii L Davis J Gorenstein H Hatch M Yashiro A Di Bacco C Elbi B Lutterbach 2008 FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival Cancer Res 68 2340 2348 18381441 10.1158/0008-5472.CAN-07-5229 1:CAS:528:DC%2BD1cXktV2jsr0%3D
21. H Sasaki M Shitara K Yokota Y Hikosaka S Moriyama M Yano Y Fujii 2012 Increased FGFR1 copy number in lung squamous cell carcinomas Mol Med Report 5 3 725 728 22179561 1:CAS:528:DC%2BC38XisFOiu7s%3D
22. KH Allison SM Dintzis RA Schmidt 2011 Frequency of HER2 heterogeneity by fluorescence in situ hybridization according to CAP expert panel recommendations: time for a new look at how to report heterogeneity Am J Clin Pathol 136 6 864 871 22095371 10.1309/AJCPXTZSKBRIP07W
23. C Behrens HY Lin JJ Lee MG Raso WK Hong II Wistuba R Lotan 2008 Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer Clin Cancer Res 14 6014 6022 18829480 10.1158/1078-0432.CCR-08-0167 1:CAS:528: DC%2BD1cXhtF2nurrO
24. I Petersen WFM Amin Kotb KH Friedrich K Schlüns A Böcking M Dietel 2009 Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters Lung Cancer 65 312 318 19168259 10.1016/j.lungcan.2008.12.013
25. T Ried I Petersen H Holtgreve-Grez MR Speicher E Schröck S du Manoir T Cremer 1994 Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization Cancer Res 54 7 1801 1806 8137295 1:STN:280:DyaK2c7osFShsw%3D%3D
26. I Petersen H Langreck G Wolf A Schwendel R Psille P Vogt MB Reichel T Ried M Dietel 1997 Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p Br J Cancer 75 1 79 86 9000602 10.1038/bjc.1997.13 1:CAS:528:DyaK2sXmsF2gsA%3D%3D
27. I Petersen M Bujard S Petersen G Wolf A Goeze A Schwendel H Langreck K Gellert M Reichel K Just S du Manoir T Cremer M Dietel T Ried 1997 Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung Cancer Res 57 12 2331 2335 9192802 1:CAS:528:DyaK2sXjvFKitrc%3D
28. S Petersen M Aninat-Meyer K Schlüns K Gellert M Dietel I Petersen 2000 Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung Br J Cancer 82 1 65 73 10638968 10.1054/bjoc.1999.0878 1:STN:280:DC%2BD3c7gt1GjtA%3D%3D
29. A Goeze K Schlüns G Wolf Z Thäsler S Petersen I Petersen 2002 Chromosomal imbalances of primary and metastatic lung adenocarcinomas J Pathol 196 1 8 16 11748636 10.1002/path.1009
30. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2002) World Health Organization Classification of Tumours, Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon, 2004
31. N Ren JC Wu QZ Dong HJ Sun HL Jia GC Li BS Sun C Dai J Shi JW Wei YY Sheng HJ Zhou QH Ye LX Qin 2011 Association of specific genotypes in metastatic suppressor HTPAP with tumor metastasis and clinical prognosis in hepatocellular carcinoma Cancer Res 71 9 3278 3286 21531764 10.1158/0008-5472.CAN-10-3100 1:CAS:528:DC%2BC3MXltlGhtbs%3D
32. RJ Monnat Jr 2010 Human RECQ helicases: roles in DNA metabolism, mutagenesis and cancer biology Semin Cancer Biol 20 5 329 339 20934517 10.1016/j.semcancer.2010.10.002 1:CAS:528:DC%2BC3cXhsV2jurzJ
33. OE Pardo C Wellbrock UK Khanzada M Aubert I Arozarena S Davidson F Bowen PJ Parker VV Filonenko IT Gout N Sebire R Marais J Downward MJ Seckl 2006 FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2 EMBO J 25 13 3078 3088 16810323 10.1038/sj.emboj. 7601198 1:CAS:528:DC%2BD28XmvFajur0%3D
34. OE Pardo J Latigo RE Jeffery E Nye R Poulsom B Spencer-Dene NR Lemoine GW Stamp EO Aboagye MJ Seckl 2009 The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo Cancer Res 69 22 8645 8651 19903855 10.1158/0008-5472.CAN-09-1576 1:CAS:528: DC%2BD1MXhtl2rsbfN
35. H Kuhn C Kopff J Konrad A Riedel C Gessner H Wirtz 2004 Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines Lung Cancer 44 167 174 15084381 10.1016/j.lungcan.2003.11.005
36. W Berger U Setinek T Mohr I Kindas-Mügge M Vetterlein G Dekan F Eckersberger C Caldas M Micksche 1999 Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells Int J Cancer 83 415 423 10495436 10.1002/(SICI)1097-0215(19991029)83:3<415::AID- IJC19>3.0.CO;2-Y 1:CAS:528:DyaK1MXntVelt7s%3D
37. F Guddo G Fontanini C Reina AM Vignola A Angeletti G Bonsignore 1999 The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression Hum Pathol 30 788 794 10414497 10.1016/S0046-8177(99)90139-9 1:CAS:528:DyaK1MXkvFejtb8%3D